Advanced Malignant Solid Tumors Completed Phase 1 Trials for Dacomitinib (DB11963)

IndicationStatusPhase
DBCOND0036787 (Advanced Malignant Solid Tumors)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00728468A Study To Test The Impact Of PF- 00299804 On How The Body Handles Dextromethorphan In Cancer Patients